BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15030527)

  • 1. Cathepsin D is up-regulated in inflammatory bowel disease macrophages.
    Hausmann M; Obermeier F; Schreiter K; Spottl T; Falk W; Schölmerich J; Herfarth H; Saftig P; Rogler G
    Clin Exp Immunol; 2004 Apr; 136(1):157-67. PubMed ID: 15030527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycoprotein (gp) 96 expression: induced during differentiation of intestinal macrophages but impaired in Crohn's disease.
    Schreiter K; Hausmann M; Spoettl T; Strauch UG; Bataille F; Schoelmerich J; Herfarth H; Falk W; Rogler G
    Gut; 2005 Jul; 54(7):935-43. PubMed ID: 15951537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivo.
    Menzel K; Hausmann M; Obermeier F; Schreiter K; Dunger N; Bataille F; Falk W; Scholmerich J; Herfarth H; Rogler G
    Clin Exp Immunol; 2006 Oct; 146(1):169-80. PubMed ID: 16968411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of inducible nitric oxide synthase (iNOS) mRNA in inflamed esophageal and colonic mucosa in a pediatric population.
    Gupta SK; Fitzgerald JF; Chong SK; Croffie JM; Garcia JG
    Am J Gastroenterol; 1998 May; 93(5):795-8. PubMed ID: 9625130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease.
    Kruidenier L; Kuiper I; van Duijn W; Marklund SL; van Hogezand RA; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):7-16. PubMed ID: 12950012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistry.
    ter Beek WP; Biemond I; Muller ES; van den Berg M; Lamers CB
    Neuropeptides; 2007 Oct; 41(5):301-6. PubMed ID: 17602742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice.
    Bamba S; Lee CY; Brittan M; Preston SL; Direkze NC; Poulsom R; Alison MR; Wright NA; Otto WR
    J Pathol; 2006 Jun; 209(2):265-73. PubMed ID: 16550633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of the ubiquitin-proteasome system in normal colonic macrophages and reinduction in inflammatory bowel disease.
    Hetzenecker AM; Seidl MC; Kosovac K; Herfarth H; Kellermeier S; Obermeier F; Falk W; Schoelmerich J; Hausmann M; Rogler G
    Digestion; 2012; 86(1):34-47. PubMed ID: 22710419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease.
    Renner M; Bergmann G; Krebs I; End C; Lyer S; Hilberg F; Helmke B; Gassler N; Autschbach F; Bikker F; Strobel-Freidekind O; Gronert-Sum S; Benner A; Blaich S; Wittig R; Hudler M; Ligtenberg AJ; Madsen J; Holmskov U; Annese V; Latiano A; Schirmacher P; Amerongen AV; D'Amato M; Kioschis P; Hafner M; Poustka A; Mollenhauer J
    Gastroenterology; 2007 Nov; 133(5):1499-509. PubMed ID: 17983803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
    Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease.
    Kruidenier L; Kuiper I; Van Duijn W; Mieremet-Ooms MA; van Hogezand RA; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):17-27. PubMed ID: 12950013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer.
    Krueger S; Kalinski T; Hundertmark T; Wex T; Küster D; Peitz U; Ebert M; Nägler DK; Kellner U; Malfertheiner P; Naumann M; Röcken C; Roessner A
    J Pathol; 2005 Sep; 207(1):32-42. PubMed ID: 16025436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine.
    Klebl FH; Olsen JE; Jain S; Doe WF
    J Pathol; 2001 Dec; 195(5):609-15. PubMed ID: 11745698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtractive screening reveals up-regulation of NADPH oxidase expression in Crohn's disease intestinal macrophages.
    Hausmann M; Spöttl T; Andus T; Rothe G; Falk W; Schölmerich J; Herfarth H; Rogler G
    Clin Exp Immunol; 2001 Jul; 125(1):48-55. PubMed ID: 11472425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of cytokine mRNA expression in intestinal biopsies of cats with inflammatory enteropathy using quantitative real-time RT-PCR.
    Nguyen Van N; Taglinger K; Helps CR; Tasker S; Gruffydd-Jones TJ; Day MJ
    Vet Immunol Immunopathol; 2006 Oct; 113(3-4):404-14. PubMed ID: 16879876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivation of inflammatory bowel disease in a mouse model of depression.
    Ghia JE; Blennerhassett P; Deng Y; Verdu EF; Khan WI; Collins SM
    Gastroenterology; 2009 Jun; 136(7):2280-2288.e1-4. PubMed ID: 19272381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel anti-inflammatory action of 5-aminoimidazole-4-carboxamide ribonucleoside with protective effect in dextran sulfate sodium-induced acute and chronic colitis.
    Bai A; Yong M; Ma AG; Ma Y; Weiss CR; Guan Q; Bernstein CN; Peng Z
    J Pharmacol Exp Ther; 2010 Jun; 333(3):717-25. PubMed ID: 20237071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase A2 activating protein and idiopathic inflammatory bowel disease.
    Peterson JW; Dickey WD; Saini SS; Gourley W; Klimpel GR; Chopra AK
    Gut; 1996 Nov; 39(5):698-704. PubMed ID: 9014769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
    Araki A; Kanai T; Ishikura T; Makita S; Uraushihara K; Iiyama R; Totsuka T; Takeda K; Akira S; Watanabe M
    J Gastroenterol; 2005 Jan; 40(1):16-23. PubMed ID: 15692785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.